* Out of 123 patients, 25.2% developed BPT, and 13.8% experienced RP, but there was no significant correlation between BPT and the development of RP.
* The findings indicate that radiation therapy does not need to be postponed due to BPT, except for recovery from symptoms or completion of steroid treatment.
The study aimed to investigate the risk of developing Lhermitte's sign (LS) in lymphoma patients treated with chemotherapy followed by radiation therapy.
Researchers interviewed 106 patients who received radiation to the mediastinum, finding that 29% developed LS; however, no significant correlations were found with radiation dose or treatment variations.
The conclusion emphasizes that LS occurrence appears to be an idiosyncratic reaction to treatment rather than influenced by radiation dosage, potentially highlighting the effectiveness of structured interviews in assessing symptoms.